Can Magnetic resonance-ultrasound fusion biopsy improve cancer detection in enlarged prostates?

Journal of Urology

Volumn 190, Issue 6, 2013, Pages 2020-2025

  Diaz, Annerleim Walton ^a   Hoang, Anthony N ^a   Turkbey, Baris ^a   Hong, Cheng William ^a   Truong, Hong ^a   Sterling, Todd ^a   Rais Bahrami, Soroush ^a   Siddiqui, M Minhaj ^a   Stamatakis, Lambros ^a   Vourganti, Srinivas ^a   Nix, Jeffrey ^a   Logan, Jennifer ^a   Harris, Colette ^a   Weintraub, Michael ^a   Chua, Celene ^a   Merino, Maria J ^a   Choyke, Peter ^a   Wood, Bradford J ^a   Pinto, Peter A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Magnetic resonance imaging; Prostate; Prostatic hyperplasia; Prostatic neoplasms; Ultrasonography

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FOLLOW UP; GLEASON SCORE; HUMAN; INDEPENDENT VARIABLE; MAGNETIC RESONANCE ULTRASOUND FUSION BIOPSY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATE SIZE; PROSTATE VOLUME; RETROSPECTIVE STUDY; TRANSRECTAL ULTRASONOGRAPHY; TRANSRECTAL ULTRASOUND GUIDED BIOPSY;

EID: 84888636994     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2013.05.118     Document Type: Article

References (30)

1. American Cancer Society: Prostate Cancer. Available at http://www.cancer.org/cancer/prostatecancer/detailedguide/prostate- cancerkeystatistics United States of America 2013. Accessed February 27, 2012.
2. Hodge KK, McNeal JE, Terris MK et al: Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 1989;142:.
3. Heidenreich A, Bellmunt J, Bolla M et al: EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. Eur Uro 2011;59:61.
4. Ung JO, San Francisco IF, Regan MM et al: The relationship of prostate gland volume to extended needle biopsy on prostate cancer detection. J Urol 2003;169:130.
5. Karakiewicz PI, Bazinet M, Aprikian AG et al: Outcome of sextant biopsy according to gland volume. Urology 1997;49:55.
6. Werahera PN, Sullivan K, Rosa FG et al: Optimization of prostate cancer diagnosis by increasing the number of core biopsies based on gland volume. Int J Clin Exp Pathol 2012;5:892.
7. Yoon BI, Shin TS, Cho HJ et al: Is it effective to perform two more prostate biopsies according to prostate-specific antigen level and prostate volume in detecting prostate cancer? Prospective study of 10-core and 12-core prostate biopsy. Urology 2012;9:491.
8. de la Taille A, Antiphon P, Salomon L et al: Prospective evaluation of a 21-sample needle biopsy procedure designed to improve the prostate cancer detection rate. Urology 2003;61:1181.
9. Isebaert S, Van den Bergh L, Haustermans K et al: Multiparametric MRI for prostate cancer localization in correlation to whole-mount histopathology. J Magn Reson Imaging 2013;37:1392.
10. Natarajan S, Marks LS, Margolis DJ et al: Clinical application of a 3D ultrasound-guided prostate biopsy system. Urol Oncol 2011;29:334.
11. Singh AK, Kruecker J, Xu S et al: Initial clinical experience with real-time transrectal ultrasonography-magnetic resonance imaging fusion-guided prostate biopsy. BJU Int 2008;101:841.
12. Dickinson L, Ahmed HU, Allen C et al: Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting. Eur Urol 2011;59:477.
13. Pinto PA, Chung PH, Rastinehad AR et al: Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging. J Urol 2011;186:1281.
14. Turkbey B, Mani H, Shah V et al: Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds. J Urol 2011;186:1818.
15. Yerram NK, Volkin D, Turkbey B et al: Low suspicion lesions on multiparametric magnetic resonance imaging predict for the absence of high-risk prostate cancer. BJU Int 2012;110:E783.
16. Turkbey B, Huang R, Vourganti S et al: Agerelated changes in prostate zonal volumes as measured by high-resolution magnetic resonance imaging (MRI): a cross-sectional study in over 500 patients. BJU Int 2012;110:1642.
17. Stamey T: Making the most out of six systematic sextant biopsies. Urology 1995;45:2.
18. Ochiai A and Babaian RJ: Update on prostate biopsy technique. Curr Opin Urol 2004;14:157.
19. Chon CH, Lai FC, McNeal JE et al: Use of extended systematic sampling in patients with a prior negative prostate needle biopsy. J Urol 2002;167:2457.
20. Zaytoun OM, Moussa AS, Gao T et al: Office based transrectal saturation biopsy improves prostate cancer detection compared to extended biopsy in the repeat biopsy population. J Urol 2011;186:850.
21. Pinkstaff DM, Igel TC, Petrou SP et al: Systematic transperineal ultrasound-guided template biopsy of the prostate: three-year experience. Urology 2005;65:735.
22. Welch HG, Fisher ES, Gottlieb DJ et al: Detection of prostate cancer via biopsy in the Medicare-SEER population during the PSA era. J Natl Cancer Inst 2007;99:1395.
23. Eichler K, Hempel S, Wilby J et al: Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review. J Urol 2006;175:1605.
24. McNeal JE: Origin and evolution of benign prostatic enlargement. Invest Urol 1978;15:340.
25. McNeal JE: The zonal anatomy of the prostate. Prostate 1981;2:35.
26. Marks L, Young S and Natarajan S: MRIultrasound fusion for guidance of targeted prostate biopsy. Curr Opin Urol 2013;23:43.
27. Hadaschik BA, Kuru TH, Tulea C et al: A novel stereotactic prostate biopsy system integrating pre-interventional magnetic resonance imaging and live ultrasound fusion. J Urol 2011;186:2214.
28. Sonn GA, Chang E, Natarajan S et al: Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen. Eur Urol, Epub ahead of print March 17, 2013.
29. Harnden P, Naylor B, Shelley MD et al: The clinical management of patients with a small volume of prostatic cancer on biopsy: what are the risks of progression? A systematic review and meta-analysis. Cancer 2008;112:971.
30. Hoang AN, Volkin D, Yerram NK et al: Image guidance in the focal treatment of prostate cancer. Curr Opin Urol 2012;22:328.